Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 68.00 | |
10 mg | In stock | $ 113.00 | |
25 mg | In stock | $ 225.00 | |
50 mg | In stock | $ 378.00 | |
100 mg | In stock | $ 597.00 | |
500 mg | In stock | $ 1,260.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 75.00 |
Description | CPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2). |
In vitro | CPDA enhances insulin signaling. CPDA was found to enhance in vitro insulin signaling through the Akt pathway more efficiently than the previously reported SHIP2 inhibitor AS1949490, and ameliorated abnormal glucose metabolism in diabetic (db/db) mice. |
In vivo | CPDA greatly improves abnormal glucose metabolism in diabetic animals. In db/db mice, CPDA improves abnormal glucose metabolism. |
Molecular Weight | 388.8 |
Formula | C20H15ClF2N2O2 |
CAS No. | 1415834-63-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (128.60 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CPDA 1415834-63-7 Metabolism Phosphatase inhibit Inhibitor inhibitor